SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-003779
Filing Date
2024-01-25
Accepted
2024-01-25 17:00:16
Documents
19
Period of Report
2024-01-25
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38846
2 ex99-1.htm EX-99.1 7611
3 ex99-1_001.jpg GRAPHIC 457806
4 ex99-1_002.jpg GRAPHIC 588781
5 ex99-1_003.jpg GRAPHIC 301470
6 ex99-1_004.jpg GRAPHIC 255965
7 ex99-1_005.jpg GRAPHIC 290078
8 ex99-1_006.jpg GRAPHIC 292020
  Complete submission text file 0001493152-24-003779.txt   3229767

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE aim-20240125.xsd EX-101.SCH 3015
10 XBRL LABEL FILE aim-20240125_lab.xml EX-101.LAB 34240
11 XBRL PRESENTATION FILE aim-20240125_pre.xml EX-101.PRE 22360
13 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3212
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-27072 | Film No.: 24563048
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)